Iron facilitates the RetS-Gac-Rsm cascade to inversely regulate protease IV (piv) expression via the sigma factor PvdS in Pseudomonas aeruginosa.

Environ Microbiol

Key Laboratory of Resources Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, ShaanXi, 710069, China.

Published: December 2020

Pseudomonas aeruginosa produces several proteases, such as an elastase (LasB protease), a LasA protease, and protease IV (PIV), which are thought as significant virulence factors during infection. Regulators of LasA and LasB expression have been identified and well characterized; however, the molecular details of this regulation of protease IV (PIV) remained largely unknown. Here, we describe the interaction between protease IV and the RetS/Rsm signalling pathway, which plays a central role in controlling the production of multiple virulence factors and the switch from planktonic to biofilm lifestyle. We show that the expression of piv was reduced in ΔretS or ΔrsmA strain grown under restrictive conditions but was induced in ΔretS or ΔrsmA mutant grown under rich conditions as compared with wild-type parent. We compare the expression of piv under various conditions and found that iron facilitates RetS/Rsm system to lead this inverse regulation. Moreover, we reveal that the RetS/Rsm pathway regulates PIV production dependent on the alternative sigma factor PvdS. Collectively, this study extends the understanding of the RetS/Rsm regulatory cascade in response to environmental signals and provides insights into how P. aeruginosa adapts to the complex conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1462-2920.15270DOI Listing

Publication Analysis

Top Keywords

protease piv
12
iron facilitates
8
sigma factor
8
factor pvds
8
pseudomonas aeruginosa
8
virulence factors
8
expression piv
8
Δrets Δrsma
8
protease
6
piv
6

Similar Publications

Article Synopsis
  • Pseudomonas aeruginosa is a key player in hospital infections due to its virulence factors, especially elastase and proteases.
  • The study focuses on assessing the prevalence of specific genes (LasA, LasB, and PIV) that encode these enzymes in clinical samples of P. aeruginosa.
  • Understanding the presence of these genes can help in addressing infection control and treatment strategies in healthcare settings.
View Article and Find Full Text PDF
Article Synopsis
  • The Pan-immune inflammation value (PIV) is a new biomarker that represents systemic inflammation, derived from complete blood count data, and may indicate the body’s immune response.
  • A study evaluated the impact of pretreatment PIV on overall survival in 43 patients with metastatic castration-resistant prostate cancer who were treated with Lutetium-177 (Lu)-PSMA-617.
  • Results showed that patients with low PIV had a significantly longer median overall survival of 15.1 months compared to 4.2 months for those with high PIV, indicating that PIV could be a useful prognostic factor in this patient group.
View Article and Find Full Text PDF

LasR regulates protease IV expression at suboptimal growth temperatures in .

bioRxiv

June 2024

Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, USA.

The opportunistic pathogen causes debilitating lung infections in people with cystic fibrosis, as well as eye, burn, and wound infections in otherwise immunocompetent individuals. Many of 's virulence factors are regulated by environmental changes associated with human infection, such as a change in temperature from ambient to human body temperature. One such virulence factor is protease IV (PIV).

View Article and Find Full Text PDF

Objective: The aim of this study was to investigate the predictive value of inflammation parameters and indices measured in the first trimester for the detection of preeclampsia.

Materials And Methods: In this retrospective analysis, we examined the medical records of 276 eligible pregnancies at a tertiary referral center from 2022 to 2023. The cases were categorized into the Control group (n = 171), the Mild Preeclampsia group (n = 63), and the Severe Preeclampsia group (n = 42).

View Article and Find Full Text PDF

This study is aimed to investigate the prognostic significance of inflammation indices, including neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and pan-immune-inflammation value (PIV) in metastatic castration-resistant prostate cancer (mCRPC) patients who had received lutetium labeled prostate-specific membrane antigen (177Lu-PSMA-617) therapy. Sixty-one mCRPC patients who received 177Lu-PSMA-617 treatment and followed up in Kocaeli University were included. The relationship between overall survival (OS) and progression-free survival (PFS) and clinical and laboratory parameters was analyzed by multivariate analyses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!